Evidence map›Paper›PMID 32542603›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2020

The Self-assembly Approach as a Tool for the Tissue Engineering of a Bi-lamellar Human Cornea.

Gaëtan Le-Bel, Pascale Desjardins, Camille Couture, Lucie Germain, Sylvain L Guérin

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gaëtan Le-BelCentre universitaire d'ophtalmologie - recherche (CUO-Recherche) et, Université Laval, Québec, QC, Canada.
Pascale DesjardinsCentre universitaire d'ophtalmologie - recherche (CUO-Recherche) et, Université Laval, Québec, QC, Canada.
Camille CoutureCentre universitaire d'ophtalmologie - recherche (CUO-Recherche) et, Université Laval, Québec, QC, Canada.
Lucie GermainCentre universitaire d'ophtalmologie - recherche (CUO-Recherche) et, Université Laval, Québec, QC, Canada.
Sylvain L GuérinCentre universitaire d'ophtalmologie - recherche (CUO-Recherche) et, Université Laval, Québec, QC, Canada. Sylvain.Guerin@fmed.ulaval.ca.

Funding

CIHR FDN-143213CIHR MOP-12087
6 · The paper itself

Abstract

Tissue engineering is a flourishing field of regenerative medicine that allows the reconstruction of various tissues of our body, including the cornea. In addition to addressing the growing need for organ transplants, such tissue-engineered substitutes may also serve as good in vitro models for fundamental and preclinical studies. Recent progress in the field of corneal tissue engineering has led to the development of new technologies allowing the reconstruction of a human bi-lamellar cornea. One unique feature of this model is the complete absence of exogenous material. Indeed, these human corneal equivalents are exclusively composed of untransformed human corneal fibroblasts (hCFs) entangled in their own extracellular matrix, as well as untransformed human corneal epithelial cells (hCECs), both of which isolated from donor corneas. The reconstructed human bi-lamellar cornea thereby exhibits a well-organized stroma as well as a well-differentiated epithelium. This chapter describes the methods used for the isolation and culture of hCFs, the production and assembly of hCFs stromal sheets, the seeding of hCECs, and the maturation of the tissue-engineered cornea.

Indexed as

CorneaCorneal StromaEpithelium, CornealExtracellular MatrixFibroblastsHumansTissue EngineeringCorneaEpitheliumHuman corneal fibroblastsStromaTissue engineering

Identifiers

PMID32542603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.